Score Overview
West Pharmaceutical Services Inc fundamental performance
Between 2005 and 2025, revenue grew from $ 699M to $ 3.07B and net income grew from $ 45M to $ 493M. Revenue increased in 18 of those 20 years; net income in 15.
Across West Pharmaceutical Services Inc's full reported history, from 1985 to 2025, revenue grew from $ 190M to $ 3.07B and net income grew from $ 15M to $ 493M. Revenue increased in 85% of the years measured; net income in 68%.
West Pharmaceutical Services Inc currently holds a 20-year HDB Score of 8.1 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 352.29 | — |
1 Year2025-08-12 | $ 239.15 | 47.31% |
5 Years2021-08-12 | $ 424.11 | -16.93% |
10 Years2016-08-12 | $ 78.10 | 351.07% |
20 Years2006-08-11 | $ 15.80 | 22x |
30 Years1996-08-12 | $ 4.05 | 86x |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | 30 Years1996-08-12 |
|---|---|---|---|---|---|---|
| Price | $ 352.29 | $ 239.15 | $ 424.11 | $ 78.10 | $ 15.80 | $ 4.05 |
| Return | — | 47.31% | -16.93% | 351.07% | 22x | 86x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 3.32B | $ 564M | $ 435M |
| 2025 | $ 3.07B | $ 493M | $ 791M |
| 2024 | $ 2.89B | $ 492M | $ 484M |
| 2023 | $ 2.95B | $ 593M | $ 853M |
| 2022 | $ 2.88B | $ 585M | $ 894M |
| 2021 | $ 2.83B | $ 661M | $ 762M |
| 2020 | $ 2.14B | $ 346M | $ 615M |
| 2019 | $ 1.84B | $ 241M | $ 439M |
| 2018 | $ 1.71B | $ 206M | $ 337M |
| 2017 | $ 1.59B | $ 150M | $ 235M |
| 2016 | $ 1.50B | $ 143M | $ 203M |
| 2015 | $ 1.39B | $ 95M | $ 274M |
| 2014 | $ 1.42B | $ 127M | $ 255M |
| 2013 | $ 1.36B | $ 112M | $ 237M |
| 2012 | $ 1.26B | $ 80M | $ 174M |
| 2011 | $ 1.19B | $ 75M | $ 91M |
| 2010 | $ 1.10B | $ 65M | $ 110M |
| 2009 | $ 1.05B | $ 72M | $ 83M |
| 2008 | $ 1.05B | $ 86M | $ 91M |
| 2007 | $ 1.02B | $ 70M | $ 129M |
| 2006 | $ 913M | $ 67M | $ 47M |
| 2005 | $ 699M | $ 45M | $ 48M |
| 2004 | $ 541M | $ 19M | $ 68M |
| 2003 | $ 490M | $ 31M | $ 37M |
| 2002 | $ 419M | $ 18M | $ 33M |
| 2001 | $ 396M | -$ 5M | $ 42M |
| 2000 | $ 430M | $ 1M | $ 42M |
| 1999 | $ 469M | $ 38M | $ 45M |
| 1998 | $ 449M | $ 6M | $ 31M |
| 1997 | $ 452M | $ 44M | $ 52M |
| 1996 | $ 458M | $ 16M | $ 27M |
| 1995 | $ 412M | $ 28M | $ 17M |
| 1994 | $ 365M | $ 27M | $ 27M |
| 1993 | $ 348M | $ 23M | $ 5M |
| 1992 | $ 338M | $ 19M | $ 3M |
| 1991 | $ 329M | -$ 8M | $ 2M |
| 1990 | $ 323M | $ 4M | $ 2M |
| 1989 | $ 308M | $ 20M | $ 1M |
| 1988 | $ 288M | $ 17M | $ 5M |
| 1987 | $ 253M | $ 13M | $ 12M |
| 1986 | $ 235M | $ 17M | $ 7M |
| 1985 | $ 190M | $ 15M | $ 8M |
Explore beyond WST
You're looking at West Pharmaceutical Services Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
Explore other companies
- Universal Health Services IncUHS· revenue grew in 95% of years
- Mettler-Toledo International IncMTD· revenue grew in 85% of years
- UFP Technologies IncUFPT· revenue grew in 80% of years
- UnitedHealth Group IncorporatedUNH· revenue grew in 100% of years
- Edwards Lifesciences CorpEW· revenue grew in 95% of years
